Jellen, Leslie C.
Lewis, Mechelle M.
Du, Guangwei
Wang, Xi
Galvis, Martha L. Escobar
Krzyzanowski, Stanislaw
Capan, Colt D.
Snyder, Amanda M.
Connor, James. R.
Kong, Lan
Mailman, Richard B.
Brundin, Patrik
Brundin, Lena
Huang, Xuemei
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke Parkinson’s Disease Biomarker Program (NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008, NS082151 and NS112008)
Hershey Medical Center General Clinical Research Center (National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127, National Center for Research Resources, Grant UL1 RR033184 that is now at the National Center for Advancing Translational Sciences, Grant UL1 TR000127)
Penn State Translational Brain Research Center
Michael J Fox Foundation for Parkinson’s Research (14939, 14939, 14939, 14939, 14939, 14939, 14939, 14939, 14939)
PA Department of Health Tobacco CURE Funds
Article History
Received: 22 July 2021
Accepted: 18 November 2021
First Online: 21 December 2021
Competing interests
: Dr. Huang and Dr. Lewis have received funding from the National Institutes of Health (R01 ES019672, U01 NS082151, U01 NS112008), the Michael J. Fox Foundation, Alzheimer’s Association, Alzheimer’s Research UK, the Weston Brain Institute, Bristol Myers Squibb/Biogen, Pfizer, and the Department of Defense. Dr. Huang and Dr. Lewis also have a patent covering the use of novel imaging metrics to diagnose PD and monitor its progression. Dr. Du received funding from the National Institutes of Health (R01 ES019672, U01 NS082151, U01 NS112008), the Michael J. Fox Foundation for Parkinson’s Research, Alzheimer’s Association, Alzheimer’s Research UK, and the Weston Brain Institute. Dr. Du also has a patent covering the use of novel imaging metrics to diagnose PD and monitor its progression. Dr. Kong received funding from NINDS, NIEHS, NCATS, the Patient-Centered Outcomes Research Institute (PCORI), the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR), the National Institute of Aging (NIA), and Pfizer. Dr. Lena Brundin has received funding from the National Institute of Mental Health, the United States Department of Veterans Affairs and the Michael J Fox Foundation for Parkinson’s Research. Dr. Patrik Brundin has consulted for Axial Therapeutics, Calico, CuraSen, Fujifilm-Cellular Dynamics Inc, Idorsia and Lundbeck A/S. He has received commercial support for research from Lundbeck A/S and Roche, and has ownership interests in Acousort AB. The rest of the authors declare to have no competing interest.